Discontinuation report PMS-SUMATRIPTAN
Report ID | 149391 |
Drug Identification Number | 02256436 |
Brand name | PMS-SUMATRIPTAN |
Common or Proper name | SUMATRIPTAN |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | SUMATRIPTAN |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-11-15 |
Remaining supply date | 2021-11-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Other format available: pms-SUMATRIPTAN 50mg TABS BLIS 1X6 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-11-16 | French | Compare |
v1 | 2021-11-16 | English | Compare |
Showing 1 to 2 of 2